Steering Committee

Archana Ajmera, MSN, ANP-BC, AOCNP is a board-certified adult nurse practitioner and advanced oncology-certified nurse practitioner at US San Diego Health. She cares for patients with prostate cancer, renal cell carcinoma, urothelial carcinoma, testicular germ cell tumors and penile carcinoma, and has expertise in chemotherapy, immunotherapy, targeted therapy, and investigational agents. She plays an active role in clinical research by serving as a sub-investigator and serves as the genitourinary oncology board member for the Alliance Oncology Nursing Committee. In addition to her clinical role, Ajmera is a strong advocate for advanced APP (Advanced Practice Provider) practice and is the APP Supervisor for the Division of Hematology Oncology.

Prior to joining UC San Diego Health, Ajmera was an oncology nurse practitioner at UC San Francisco, where she cared for adults with hematologic malignancies and bone marrow transplant candidates, as well as women receiving breast cancer treatment. She was also an oncology nurse practitioner at Massachusetts General Hospital in Boston, where she managed the care of women undergoing treatment with surgery and chemotherapy for gynecologic malignancies.

Ajmera earned her master's degree in nursing from MGH Institute of Health Professions School of Nursing in Boston and earned her bachelor's degree in nutritional sciences from UC Berkeley. She is a member of the American Society of Clinical Oncology, Alliance Clinical Trials Network, Advanced Practice Society for Hematology and Oncology, and National Comprehensive Cancer Network.

Petros Grivas, MD, PhD, is a board certified oncologist at Seattle Cancer Care Alliance, a director at the University of Washington School of Medicine's genitourinary cancers program, and an associate professor of oncology.
 
Considered an international expert in genitourinary cancer, Dr. Grivas played an important role in clinical trials that led to the FDA approval of new drugs for bladder/urothelial cancer. He lectures internationally, pursues community outreach, and leads studies, and publishes novel research. He is dedicated to efficient, personalized, outstanding patient care and optima patient-physician relationships. 

Kirollos Hanna, PharmD, BCPS, BCOP, is the Director of Pharmacy at Minnesota Oncology and an Assistant Professor of Pharmacy at the Mayo Clinic College of Medicine. Dr. Hanna also serves as an Associate Editor for the Journal of the Advanced Practitioner in Oncology (JADPRO).

Dr. Hanna’s research interests are focused on B-cell malignancies and genitourinary cancers. He has published over a dozen peer-reviewed manuscripts in various journals including Pharmacotherapy, AJHP, Drugs, JOPP, AJMC and JHOP.

Dr. Hanna is board certified by the Board of Pharmacy Specialties in Oncology Pharmacy and Pharmacotherapy. He received his Doctor of Pharmacy from Florida A&M University, completed his general residency at St. Thomas Hospital, Nashville, TN and his oncology residency at St. Luke's Mountain States Tumor Institute, Boise, ID.